Trials
3 active
3 in total
Targets
—
None known yet
What this is
- How it works
- How it works isn't classified yet
- How it’s given
- “VV913 10mg Capsules, taken orally on demand, 0.5-4 hours prior to sexual intercourse”In the company’s words, NCT07722780 on ClinicalTrials.gov
- Tested for
- Premature Ejaculation
- Main trialPhase 2
- “This trial adopted a multicenter, randomized, double-blind, placebo-controlled design and consisted of two parts: Part Ⅰ and Part Ⅱ.”In the company’s words, NCT07722780 on ClinicalTrials.gov
Other drugs for Premature Ejaculation
- KH-001Kadence Bio · Phase 2
Coming up2
- 31 DecPhase 1 trial completes · ClinicalTrials.gov
- 31 Dec 2027Phase 2 trial completes · ClinicalTrials.gov
Changes0
Last 90 daysNo changes yet. We started recording changes on 6 Nov 2026.
Trials3
| Trial | Phase | Completes | What it tests |
|---|---|---|---|
| Phase 2Not yet recruiting | 31 Dec 2027 | Evaluate the Efficacy and Safety of VV913 Capsules in the Treatment of PE | |
| Phase 1Recruiting | Sep 2026 | Study of the Safety, Tolerability, Pharmacokinetics of VV913 Capsules in Chinese Healthy Participants | |
| Phase 1Recruiting | 31 Dec 2026 | Study of Food Effects of VV913 Capsules in Chinese Healthy Volunteers |
A trial in both registries shows both numbers.
About
- Sources
- ClinicalTrials.gov updated 19 Nov 2026 · EU trials register (CTIS) updated 19 Nov 2026 · openFDA updated 19 Nov 2026